Today’s issue of WorkCompRecap features myMatrixx’s release of their 12th annual Drug Trends Report, which found that workers’ compensation pharmacy spending decreased 3.3% in 2017, and opioid utilization declined for the seventh consecutive year.
Key findings from the report included that the decrease in drug spending was driven primarily by decreases in per-user-per-year (PUPY) utilization, which decreased by 4.4% between 2016 and 2017. Drug spend on opioids also declined 11.9% for workers’ comp payers last year, and across payers, morphine-equivalent dose (MED) trend continued to decline, with a 33.7% reduction in cumulative MED>100 and a 26.9% decrease in cumulative MED overall. myMatrixx also noted that for the third year in a row, spending on compounded medications decreased, posting a decline of 37.9% in 2017, and it has fallen out of the top 10 therapy classes.
Find out more (including a link to the free report!) by clicking here!